HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kinetin expands in Asia

This article was originally published in The Rose Sheet

Executive Summary

Kinetin-based skin care products will be sold through physicians in Taiwan and Hong Kong starting in the second half of 2003 under licensing agreement between Senetek and Taiwan-based Panion & BF Biotech, Napa, Calif. firm states March 12. Agreement with cosmeceuticals marketer also calls for development of additional proprietary Kinetin-based products, Senetek says. Panion & BF Biotech is "invaluable partner" in expanding ingredient in Asia, Senetek adds, noting expansion into China, Thailand, Singapore, Malaysia and Vietnam also are under review. Senetek signed deal last year with Rohto Pharmaceutical to market Kinetin products in Japanese drug store channel (1"The Rose Sheet" July 1, 2002, In Brief)...

You may also be interested in...

Kinetin in Japan

Senetek signs licensing agreement with Rohto Pharmaceutical for marketing of products containing Kinetin in the Japanese drug store channel, Napa, Calif. firm says. Senetek also in licensing negotiations with a Japanese cosmetics company to distribute products containing Kinetin in prestige sector under three "well-known" trademarks, firm adds. Revlon markets a line of Kinetin-containing products under the Almay brand, and The Body Shop also sells a Kinetin skin care line (1"The Rose Sheet" March 19, 2001, p. 7 and 2"The Rose Sheet" Feb 19, 2001, p. 6)...

DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss

The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.

Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?

To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts